We also identified a number of other myeloid dendritic cell (DC) types, including BATF3+ DCs required for effector T cell trafficking and adoptive T cell therapy35, CD1c+ DCs which prime cytotoxic T cell responses36, Tumor-associated LAMP3 + DCs37,38, and LILRA4+ plasmacytoid dendritic cells39. This evidence concerns the gene LILRA4 and neoplasm.